Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the Medtronic spinal division 07-Jan-2025 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art.

Kuros Biosciences USA entered into a five-year exclusive sales agency agreement with Medtronic spinal division.